Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2357-2362

  Warzocha, K ^a   Bienvenu, J ^a   Ribeiro, P ^a   Moullet, I ^a   Dumontet, C ^a   Neidhardt Berard, E M ^a   Coiffier, B ^a   Salles, G ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Hodgkin's disease; Ligand; Prognosis; Receptor; Tumour recrosis factor

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; CYTOKINE RECEPTOR; FIBRINOGEN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0031777592     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.391     Document Type: Article

References (21)